Results 21 to 30 of about 1,887 (161)

Population pharmacokinetic analyses for telavancin using data from healthy subjects and patients with infections. [PDF]

Antimicrob Agents Chemother
Click on the Resource Link to access the article (may not be free).Telavancin is an intravenously administered lipoglycopeptide antibiotic active against clinically relevant gram-positive pathogens.
Van Wart SA, Safir MC, Bhavnani SM, Lodise TP, Rubino CM.   +4 more
europepmc   +2 more sources

National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020

Journal of Global Antimicrobial Resistance, 2021
: Objectives: The aim of this study was to investigate the trends in serotypes and in vitro antimicrobial susceptibility of Streptococcus pneumoniae causing adult invasive pneumococcal disease (IPD) to dalbavancin, telavancin, tedizolid, eravacycline ...
Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, Min-Chi Lu, Pei-Lan Shao, Po-Liang Lu, Shu-Hsing Cheng, Chi-Ying Lin, Ting-Shu Wu, Muh-Yong Yen, Lih-Shinn Wang, Chang-Pan Liu, Wen-Sen Lee, Zhi-Yuan Shi, Yao-Shen Chen, Fu-Der Wang, Shu-Hui Tseng, Yu-Hui Chen, Wang-Huei Sheng, Chun-Ming Lee, Yen-Hsu Chen, Wen-Chien Ko, Po-Ren Hsueh   +22 more
doaj   +1 more source

Resistance to Critical Important Antibacterials in Staphylococcus pseudintermedius Strains of Veterinary Origin

Antibiotics, 2022
Staphylococcal infections represent a challenge in companion animals and hospitalized patients. This study aimed to assess the resistance of Staphylococcus pseudintermedius isolates, against a broad panel of antibacterials, including exclusive to human ...
Alessandro Bellato, Patrizia Robino, Maria Cristina Stella, Laura Scarrone, Daniela Scalas, Patrizia Nebbia   +5 more
doaj   +1 more source

Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis.

PLoS ONE, 2021
ObjectiveTo compare between current evidence of novel glycopeptides against vancomycin for the treatment of gram-positive bacterial infections.MethodologyA systematic review and meta-analysis was done.
Wissal Jame, Bilgen Basgut, Abdikarim Abdi   +2 more
doaj   +1 more source

Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)

Drugs - Real World Outcomes, 2019
Background Telavancin—a lipoglycopeptide antibacterial agent active against Gram-positive pathogens including methicillin-sensitive and -resistant Staphylococcus aureus (MRSA)—is approved in the USA for once-daily intravenous use.
Adam M. Bressler, Ali A. Hassoun, Louis D. Saravolatz, Valerie Ravenna, Chris N. Barnes, Bibiana Castaneda-Ruiz   +5 more
doaj   +1 more source

Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management

Microorganisms, 2021
Nosocomial pneumonia (NP), including hospital-acquired pneumonia in non-intubated patients and ventilator-associated pneumonia, is one of the most frequent hospital-acquired infections, especially in the intensive care unit.
Elena Xu, David Pérez-Torres, Paraskevi C. Fragkou, Jean-Ralph Zahar, Despoina Koulenti   +4 more
doaj   +1 more source

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis

BMC Infectious Diseases, 2021
Background Delafloxacin is a novel fluoroquinolone with broad antibacterial activity against pathogens causing acute bacterial skin and skin structure infections (ABSSSI).
Ioanna Vlachaki, Matteo Vacchelli, Daniela Zinzi, Edel Falla, Yilin Jiang, Theo Mantopoulos, Dilip Nathwani   +6 more
doaj   +1 more source

Staphylococcus Infection: Relapsing Atopic Dermatitis and Microbial Restoration

Antibiotics, 2023
Atopic Dermatitis (AD) skin is susceptible to Staphylococcus aureus (SA) infection, potentially exposing it to a plethora of toxins and virulent determinants, including Panton-Valentine leukocidin (PVL) (α-hemolysin (Hla) and phenol-soluble modulins ...
John Hulme
doaj   +1 more source

Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials

Infectious Diseases and Therapy, 2019
Introduction The efficacy and safety of telavancin versus vancomycin in microbiologically evaluable patients with hospital-acquired or ventilator-associated pneumonia (HAP/VAP) caused by Staphylococcus aureus with vancomycin minimum inhibitory ...
Michael S. Niederman, Patrick C. Lee, Steven L. Barriere, Chris N. Barnes, Bibiana Castaneda-Ruiz   +4 more
doaj   +1 more source

Production of the Ramoplanin Activity Analogue by Double Gene Inactivation. [PDF]

PLoS ONE, 2016
Glycopeptides such as vancomycin and telavancin are essential for treating infections caused by Gram-positive bacteria. But the dwindling availability of new antibiotics and the emergence of resistant bacteria are making effective antibiotic treatment ...
Jungang Han, Junsheng Chen, Lei Shao, Junliang Zhang, Xiaojing Dong, Pengyu Liu, Daijie Chen   +6 more
doaj   +1 more source